PharMEDium Introduces Innovative New Admixture Label Design

Monday, June 9, 2008 General News
Email Print This Page Comment
Font : A-A+

SEATTLE, June 9 PharMEDium Services, LLC, the leadingprovider of outsourced hospital pharmacy I.V. compounded solutions, haslaunched an enhanced labeling platform. The new design is intended to enhancequality of care in the OR while maximizing resources.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051202/PHARMEDIUMLOGO)

The company announced the initiative at the American Society ofHealth-System Pharmacists' Summer Meeting and exhibition here.

The national initiative, the first of its kind in the outsourcedcompounding industry, was designed as a result of extensive research intocurrent hospital labeling practices including a comprehensive failure andeffects mode (FMEA) analysis around the overall readability of admixturelabels and representation of critical drug information (e.g., drug name andconcentration). This FMEA analysis led to the development of copyrighted,patent-pending warning statements that alert clinicians to appropriate dosingguidelines by drug category, said Rich Kruzynski, R.Ph., President,PharMEDium.

"The enhanced labeling platform aligns with the recommendations ofnational leaders involved in medication error-related quality and patientsafety improvements, such as the Joint Commission," Kruzynski said. We areclearly taking strong steps to be part of the solution in improving resourceutilization while supporting improvement in the quality of patient care."

The enhanced labeling will be implemented across all compounding servicesduring 2008, Kruzynski said. Initially, the new labels will apply to fourI.V. patient controlled analgesia (PCA) pain management drugs -- morphine,fentanyl, hydromorphone, and meperidine, as well as local anesthetics forepidural and peripheral nerve block therapy. "The platform will differentiatevarious PCA drugs in our service offering and doses within each drug family,"he noted. "Upgraded I.V. PCA labels will first affect cassettes, syringes,and PCA vials. Over the remainder of 2008, we will be enhancing the labelingthroughout our service platform."

About PharMEDium Services, LLC

For more than 15 years, PharMEDium has been the leading provider ofoutsourced compounding services. In that time, PharMEDium has grown into anationwide network of state licensed and federally registered compoundingcenters providing trusted solutions to more than 1,800 hospitals throughoutthe United States. Managed by licensed pharmacists and staffed by certifiedtechnicians, the company complies with all applicable state laws and FDAregulations, including USP Chapter < 797 > and DEA requirements.Contact: Amy Langan, MEDIA INQUIRIES: Jon Ross, PharMEDium Director Ross Consulting & of Marketing Communications 847/457-2327 773-271-0677 Email: info@pharmedium.com Email: jross1chi@prodigy.net

SOURCE PharMEDium Services, LLC


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook